Brokerages expect Cavium (NASDAQ:CAVM) to post $259.99 million in sales for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Cavium’s earnings, with estimates ranging from $255.00 million to $265.00 million. Cavium posted sales of $229.58 million in the same quarter last year, which suggests a positive year-over-year growth rate of 13.2%. The firm is expected to announce its next quarterly earnings results on Wednesday, April 25th.
On average, analysts expect that Cavium will report full-year sales of $1.11 billion for the current year, with estimates ranging from $1.09 billion to $1.13 billion. For the next fiscal year, analysts forecast that the firm will report sales of $1.26 billion per share, with estimates ranging from $1.22 billion to $1.30 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that follow Cavium.
Cavium (NASDAQ:CAVM) last issued its quarterly earnings data on Wednesday, January 31st. The semiconductor provider reported $0.83 EPS for the quarter, topping analysts’ consensus estimates of $0.81 by $0.02. Cavium had a negative net margin of 7.00% and a positive return on equity of 14.07%. The firm had revenue of $260.36 million for the quarter, compared to analyst estimates of $260.05 million. During the same quarter in the previous year, the business posted $0.56 EPS. The firm’s revenue was up 15.1% compared to the same quarter last year.
A number of equities analysts have commented on the stock. ValuEngine lowered shares of Cavium from a “hold” rating to a “sell” rating in a report on Thursday. BidaskClub lowered shares of Cavium from a “hold” rating to a “sell” rating in a report on Wednesday, April 4th. Raymond James lowered shares of Cavium from an “outperform” rating to a “market perform” rating and set a $80.00 price objective on the stock. in a report on Friday, February 2nd. Stifel Nicolaus boosted their price objective on shares of Cavium from $68.00 to $81.00 and gave the stock a “hold” rating in a report on Thursday, February 1st. Finally, Zacks Investment Research upgraded shares of Cavium from a “sell” rating to a “hold” rating in a report on Tuesday, January 23rd. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and seven have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $79.33.
In other news, Director Sanjay Mehrotra sold 12,500 shares of the business’s stock in a transaction dated Friday, March 9th. The shares were sold at an average price of $91.20, for a total value of $1,140,000.00. Following the completion of the sale, the director now owns 85,511 shares of the company’s stock, valued at approximately $7,798,603.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Vincent P. Pangrazio sold 8,000 shares of the business’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $87.19, for a total transaction of $697,520.00. Following the sale, the senior vice president now directly owns 54,577 shares of the company’s stock, valued at approximately $4,758,568.63. The disclosure for this sale can be found here. Insiders sold a total of 353,962 shares of company stock valued at $31,361,100 in the last three months. Insiders own 4.65% of the company’s stock.
Several large investors have recently made changes to their positions in the stock. BlackRock Inc. grew its position in shares of Cavium by 4.7% during the 4th quarter. BlackRock Inc. now owns 3,282,964 shares of the semiconductor provider’s stock valued at $275,211,000 after buying an additional 146,534 shares during the last quarter. Deutsche Bank AG grew its position in shares of Cavium by 194.7% during the 4th quarter. Deutsche Bank AG now owns 1,278,438 shares of the semiconductor provider’s stock valued at $107,168,000 after buying an additional 844,622 shares during the last quarter. Bank of New York Mellon Corp grew its position in shares of Cavium by 33.4% during the 4th quarter. Bank of New York Mellon Corp now owns 881,869 shares of the semiconductor provider’s stock valued at $73,928,000 after buying an additional 220,651 shares during the last quarter. Janus Henderson Group PLC grew its position in shares of Cavium by 16.6% during the 3rd quarter. Janus Henderson Group PLC now owns 867,072 shares of the semiconductor provider’s stock valued at $57,170,000 after buying an additional 123,567 shares during the last quarter. Finally, Alpine Associates Management Inc. bought a new stake in shares of Cavium during the 4th quarter valued at about $69,825,000. 92.11% of the stock is owned by institutional investors and hedge funds.
CAVM stock traded down $1.47 during trading on Friday, reaching $77.13. The stock had a trading volume of 609,459 shares, compared to its average volume of 816,980. Cavium has a 1-year low of $56.96 and a 1-year high of $92.66. The company has a debt-to-equity ratio of 0.78, a current ratio of 2.80 and a quick ratio of 2.26. The firm has a market capitalization of $5,490.13, a P/E ratio of 964.13, a P/E/G ratio of 1.97 and a beta of 1.34.
ILLEGAL ACTIVITY WARNING: “$259.99 Million in Sales Expected for Cavium (CAVM) This Quarter” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/22/259-99-million-in-sales-expected-for-cavium-cavm-this-quarter.html.
Cavium, Inc designs, develops, and markets semiconductor processors for intelligent and secure networks in the United States and internationally. The company offers integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage, and security applications.
Get a free copy of the Zacks research report on Cavium (CAVM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cavium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium and related companies with MarketBeat.com's FREE daily email newsletter.